Cancer is still a major factor threatening human life around the world, and anticancer drugs remain huge unmet clinical need. Here, we reviewed novel including new molecular entities therapeutic biologics approved in US, EU, Japan, China that represent main advances drug research development 2020. Small molecule inhibitors targeting oncogenes, antibodies, antibody conjugates (ADCs) are were Mor...